Augustina Isioma Ikusemoro: Transfusion Should Be Based on Clinical Need, Not Just Numbers
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Transfuse the patient – not the number
A laboratory value alone should never be the reason a patient receives blood.
Blood transfusion is a powerful, life-saving therapy – but it is not risk – free, and it is not routine care.
Every unit transfused must answer one critical question:
Does this patient truly need it right now?
Clinical transfusion decisions should always consider:
- Symptoms of inadequate oxygen delivery
- Ongoing or active bleeding
- Cardiovascular risk status
- Acute clinical conditions (ACS, stroke, major surgery)
- Physiological reserve and comorbidities
- Hemoglobin thresholds in stable/hospitalized patients ( less than seven grams per deciliter)
Because unnecessary transfusions expose patients to real risks:
- Transfusion reactions
- Trali
- Taco
- Immunomodulation
- Iron overload
- Residual infection risk
- Loss of scarce blood resources for those in urgent need
Good transfusion practice is not about correcting numbers.
It is about protecting patients.
Safe transfusion starts with:
- The right patient
- The right indication
- The right timing
Better outcomes happen when transfusion decisions are clinically justified, evidence-guided, and patient-centered.
Signature of Blood Doki
- Educate.
- Empower.
- Elevate.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Apr 9, 2026, 14:20Julie Cardoso: Post-Thrombotic Syndrome – The Hidden Impact of DVT
-
Apr 9, 2026, 13:52Amlan Datta: When Do We Actually Use Dual Antiplatelet Therapy in Stroke Prevention?
-
Apr 9, 2026, 12:25Tara Lech: Key Pharmacotherapy Recommendations for Pulmonary Embolism
-
Apr 9, 2026, 12:18Sarah Sewaralthahab Joins the Editorial Board of Blood Global Hematology
-
Apr 9, 2026, 11:15Gopal Patidar: A Global Snapshot of Gaps in Transfusion Safety and Traceability
-
Apr 8, 2026, 18:14Simon Fletcher: The Unique Challenges PwH Face During Their Gene Therapy Journey
-
Apr 8, 2026, 17:56Hisam Siddiqi: Understanding Bone Marrow Trephine Morphology in MPNs
-
Apr 8, 2026, 17:46Mohamed Reda: Why Some Veins Decide to Take a ‘Detour’?
-
Apr 8, 2026, 17:39Managing Acquired Von Willebrand Syndrome in a Swine Polytrauma Model During ECLS – JTH